Global /South Korea /Healthcare /Drug Manufacturers - General /330350

WITHUS PHARMACEUTICAL Co.,LTD.

330350

• KRX: 330350 • Delayed

9,070KRW -0.9%

5.94 USD

As of 13 June 2026, WITHUS PHARMACEUTICAL Co.,LTD. has a market cap of $78.74M USD, ranking #27264 globally and #1395 in South Korea. It ranks #2450 in the Healthcare sector, and #884 in the Drug Manufacturers - General industry.

Global Rank

27264

Country Rank

1395

Sector Rank

2450

Industry Rank

884

Key Stats

Market Cap

$78.74MUSD

119.74B KRW

Enterprise Value

$77.99MUSD

119.03B KRW

Revenue (TTM)

$69.99MUSD

106.44B KRW

EBITDA (TTM)

$6.39MUSD

9.75B KRW

Net Income (TTM)

$3.27MUSD

4.97B KRW

EBITDA Margin

9.2%

Profit Margin

4.7%

PE Ratio

24.1

PS Ratio

1.1

PB Ratio

1.2

EV/EBITDA

12.2

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Dae-young Sung open_in_new

Employees

121

Founded

2004

Website

withuspharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.9%	-6.7%	9.6%	4.8%	35%	6.1%	39%	18%	-29%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	330350 위더스제약(주) Ordinary Shares ISIN: KR7330350000 Shares Out.: Shares Outstanding: 13.2M¹ Shares Float: 6.103M² TV: TradingView: KRX: 330350 SA: Stock Analysis: KRX: 330350 YF: Yahoo Finance: 330350.KS GF: Google Finance: KRX: 330350 BA: Barron's: 330350 MS: Morningstar: XKRX: 330350	9,070 KRW	TV: TradingView: KRX: 330350 SA: Stock Analysis: KRX: 330350 YF: Yahoo Finance: 330350.KS GF: Google Finance: KRX: 330350 BA: Barron's: 330350 MS: Morningstar: XKRX: 330350

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About WITHUS PHARMACEUTICAL Co.,LTD.

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name to WITHUS PHARMACEUTICAL Co.,LTD. in October 2007. WITHUS PHARMACEUTICAL Co.,LTD. was founded in 2004 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 12K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 9K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 7K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 6K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 6K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 6K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 967K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 695K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 458K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 408K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 367K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 349K%	20.5	Switzerland

chevron_leftBack